AcuCort’s application for ethical review for a questionnaire study on allergy treatment is approved
8 juni, 2022
Press Releases and news in Swedish/English can be found here.
AcuCort’s application for ethical review for a questionnaire study on allergy treatment is approved
8 juni, 2022
AcuCort applies for ethical review for a questionnaire study on allergy treatment
26 april, 2022
AcuCort publishes the Annual Report for 2021
12 april, 2022
Changed date for Annual General Meeting in AcuCort
23 mars, 2022
AcuCort is exempted from the application fee by the U.S. Food and Drug Administration
1 mars, 2022
22 februari, 2022
17 februari, 2022
15 november, 2021
AcuCort’s drug ISICORT® demonstrates a three-year shelf life
5 oktober, 2021
AcuCort receives a second US patent protection for its drug ISICORT®
3 september, 2021